GERN Geron Corporation

1.44
0  0%
Previous Close 1.44
Open 1.45
Price To Book 1.74
Market Cap 271,329,273
Shares 188,423,106
Volume 1,041,780
Short Ratio
Av. Daily Volume 1,457,182

NewsSee all news

  1. Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    MENLO PARK, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 240,000 shares of Geron common stock as

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 portion of trial has commenced - August 9, 2019. Data due mid-2022.
Imetelstat - IMerge Study
Myelodysplastic syndromes
Janssen noted September 27, 2018 not to continue collaboration. Decision on future development due by 3Q 2019.
Imetelstat - IMbarkStudy
Myelofibrosis

Latest News

  1. Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    MENLO PARK, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 240,000 shares of Geron common stock as